HELIXMITH CO., LTD

Other languages Helixmith Co., Ltd

Equities

A084990

KR7084990001

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
4,230 ^KRW	+1.44%		+0.24%	-31.44%

25/04	Helixmith Co., Ltd announced that it has received KRW 3.37919826 billion in funding	CI
05/02	Helixmith Co., Ltd announced that it expects to receive KRW 3.37919826 billion in funding	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Helixmith Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15
South Korean Stocks Decline Nearly 2% over Rate Hike Fears in the US; Samsung Loses 2%	23/22/23
Helixmith Announces Topline Results from Phase 2A Study of Engensis for Treatment of ALS (Amyotrophic Lateral Sclerosis)	06/22/06
Helixmith Announces Topline Results from Double-Blind Placebo Controlled Multicenter Study for TADIOS Involving 100 Subjects Infected with COVID-19	03/22/03
Paper Reporting Results from Helixmith's Phase 3 Gene Therapy Trial for Painful Diabetic Neuropathy was One of the Top-10 Most-Downloaded Articles in Clinical and Translational Science	14/22/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW